/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at a market cap of $57.4 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions provider. The company specializes in pharmaceutical sourcing and distribution, providing a comprehensive range of services to healthcare providers and biopharmaceutical manufacturers throughout the U.S. and internationally.
Cencora is slated to announce its fiscal Q3 2025 earnings results on Wednesday, Aug. 06. Ahead of the event, analysts forecast the company to report an adjusted EPS of $3.78, up 13.2% from $3.34 in the year-ago quarter. COR has surpassed Wall Street's bottom-line estimates in the past four quarterly reports.